Sms Pharmaceuticals Limited, a active public limited company, was established on 14 December 1987 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24239TG1987PLC008066. Registered under ROC Roc Hyderabad. it is listed on BSE: 532815 and NSE: SMSPHARMA. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹9.37 Cr.
Formerly known as S.M.S. Pharmaceuticals Private Limited, Sms Pharmaceuticals Pvt Limited. It upholds a compliant status. In 2024, it reported revenue of ₹713.72 Cr and a net worth of ₹570.49 Cr. Employing 1,193 professional, Its leadership includes Srinivas Sarvepalli (Director), Vamsi Krishna Potluri (Whole-Time Director), Shravan Kudaravalli (Director). Past directors included Srinivas Sarvepalli, Uma Maheswaram Kuravi, Shilpa R Waghmare. It holds ₹600.28 Cr open charges and ₹640.70 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 72, H.No: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Telangana, 500034.
L24239TG1987PLC008066
008066
14 December 1987
₹12.00 Cr
₹9.37 Cr
Roc Hyderabad
Listed (BSE: 532815, NSE: SMSPHARMA)
Active
Explore comprehensive insights into Sms Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Sarvepalli | Director | 12 Aug 2019 | Current |
| Vamsi Krishna Potluri | Whole-Time Director | 05 Jun 2020 | Current |
| Shravan Kudaravalli | Director | 26 May 2018 | Current |
| Ramesh Babu Potluri | Managing Director | 01 Dec 2008 | Current |
| Trilok Potluri | Director | 12 Aug 2024 | Current |
| Shanti Sree Bolleni | Director | 12 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Nominee Director | 18 Apr 2012 | Past |
| Pramod Abcsdd | Nominee Director | 08 Aug 2022 | Past |
| Pramod Abcsdd | Nominee Director | 31 Jan 2019 | Past |
| Pramod Abcsdd | Director | 09 Oct 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sms Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 35.45% increase. The company also saw a substantial improvement in profitability, with a 1110.03% increase in profit. The company's net worth Soared by an impressive increase of 15.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sms Pharmaceuticals had a promoter holding of 64.67% and a public holding of 35.32%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,002,820,000.00
₹6,407,039,680.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2025 | Axis Bank Limited | ₹34.15 Cr | Open |
| 14 Feb 2024 | Others | ₹100.00 Cr | Open |
| 24 Jan 2023 | Idbi Bank Limited | ₹25.00 Cr | Open |
| 08 Mar 2022 | Others | ₹16.09 Cr | Open |
| 25 Feb 2022 | State Bank Of India | ₹23.20 Cr | Open |
Explore comprehensive loan charge details -
Sms Pharmaceuticals has a workforce of 1193 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sms Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sms Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 02 Nov 2023 via Charge ID 100819428 with Others was fully satisfied on 28 Oct 2025. was documented.
A charge with Axis Bank Limited amounted to Rs. 34.15 Cr with Charge ID 101182903 was registered on 22 Oct 2025. was recorded as a recent event.
Progress on Sms Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
The activity A charge with Others of Rs. 40.00 Cr registered on 24 Jun 2016 with Charge ID 100035079 was modified on 10 Jun 2025. was completed.
Sms Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
The activity A charge with Idbi Bank Limited of Rs. 68.00 Cr registered on 11 Nov 2014 with Charge ID 10535013 was modified on 27 Mar 2025. was completed.
The CIN of Sms Pharmaceuticals Limited is L24239TG1987PLC008066.
Sms Pharmaceuticals Limited is headquartered at Plot No. 72, H.No: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Telangana, 500034.
Sms Pharmaceuticals Limited was incorporated on 14 December 1987.
The current directors of Sms Pharmaceuticals Limited are
The primary industry of Sms Pharmaceuticals Limited is Manufacturing.
Sms Pharmaceuticals Limited is listed. It is listed on BSE: 532815 and NSE: SMSPHARMA.
The authorized capital of Sms Pharmaceuticals Limited is ₹12.00 Cr, and the paid-up capital is ₹9.37 Cr.
The compliance status of Sms Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX